Jason Pitofsky, SVP Controller at Regeneron Pharmaceuticals ($REGN), sold about $1.87 million in company shares across 12 open market transactions over the past year. His most recent sale occurred on February 9, 2026. These sales rank 3,634th among 11,678 individual insiders in our database, where the average is $8.6 million per seller over about 6.4 trades. Pitofsky made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | M | Non-Qualified Stock Option (right to buy) | 1000 | $0.00 | 905.0000 | 137,600,000 | 52.49% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | M | Common Stock | 1000 | $492.00 | 6,518.0000 | 137,600,000 | 18.12% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 20 | $775.95 | 6,498.0000 | 137,600,000 | 0.31% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 521 | $776.43 | 5,977.0000 | 137,600,000 | 8.02% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 391 | $777.51 | 5,586.0000 | 137,600,000 | 6.54% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 563 | $778.35 | 5,023.0000 | 137,600,000 | 10.08% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 205 | $779.56 | 4,818.0000 | 137,600,000 | 4.08% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 75 | $780.06 | 4,743.0000 | 137,600,000 | 1.56% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 26 | $781.37 | 4,717.0000 | 137,600,000 | 0.55% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 37 | $782.67 | 4,680.0000 | 137,600,000 | 0.78% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 144 | $783.23 | 4,536.0000 | 137,600,000 | 3.08% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 1 | $784.66 | 4,535.0000 | 137,600,000 | 0.02% | 0.00% |
| Feb. 9, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | SVP Controller | S | Common Stock | 53 | $785.72 | 4,482.0000 | 137,600,000 | 1.17% | 0.00% |
| Dec. 5, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | A | Non-Qualified Stock Option (right to buy) | 2261 | $0.00 | 2,261.0000 | 136,200,000 | 9999.99% | 0.00% |
| Dec. 8, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | F | Common Stock | 989 | $712.94 | 5,518.0000 | 136,200,000 | 15.20% | 0.00% |
| Dec. 5, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | A | Common Stock | 2064 | $0.00 | 6,507.0000 | 136,200,000 | 46.46% | 0.00% |
| Nov. 7, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | S | Common Stock | 431 | $651.43 | 4,443.0000 | 136,200,000 | 8.84% | 0.00% |
| Dec. 16, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | F | Common Stock | 298 | $730.81 | 4,854.0000 | 135,300,000 | 5.78% | 0.00% |
| Dec. 6, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | A | Common Stock | 907 | $0.00 | 5,301.0000 | 135,300,000 | 20.64% | 0.00% |
| April 4, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | G | Common Stock | 89 | $0.00 | 5,062.0000 | 134,199,999 | 1.79% | 0.00% |
| Dec. 9, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | F | Common Stock | 149 | $787.00 | 5,152.0000 | 135,300,000 | 2.81% | 0.00% |
| Dec. 6, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | A | Non-Qualified Stock Option (right to buy) | 3236 | $0.00 | 3,236.0000 | 135,300,000 | 9999.99% | 0.00% |
| April 29, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | G | Common Stock | 90 | $0.00 | 5,152.0000 | 134,199,999 | 1.78% | 0.00% |
| Aug. 7, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | M | Common Stock | 487 | $372.46 | 4,701.0000 | 134,800,000 | 11.56% | 0.00% |
| Aug. 7, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | S | Common Stock | 487 | $1070.00 | 4,214.0000 | 134,800,000 | 10.36% | 0.00% |
| Aug. 7, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Pitofsky Jason | VP Controller | M | Non-Qualified Stock Option (right to buy) | 487 | $0.00 | 0.0000 | 134,800,000 | 100.00% | 0.00% |